Researchers also suggest potential new genetic associations with macular edema, which warrant further research. A study published in Scientific Reports confirmed previously identified retinal ...
DANVERS, Mass., (GLOBE NEWSWIRE) -- Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received approval for implementation of a Continuous Access ...
In a longitudinal cohort study, researchers identified 17 seemingly novel variants of the PDE6A retinitis pigmentosa gene, suggesting it may be amenable to gene therapy. RP is a degenerative retinal ...
At the most recent follow-up, subjects in the study showed a mean improvement from baseline in visual acuity of + 23 letters in the treated eye. The untreated control eyes did not show meaningful ...
FDA POST APPROVAL STUDY DEMONSTRATES TIMELY IDENTIFICATION OF RIGHT HEART FAILURE AND EARLY USE OF IMPELLA RP LEADS TO HIGHER SURVIVAL Nearly two years of real-world outcomes data on Abiomed’s (NASDAQ ...
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc. today announced presentations at the prestigious Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting. Following the ...
Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results